Related Experiment Video
Updated: May 10, 2026

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
Published on: April 14, 2014
Conventional and advanced imaging in neuromyelitis optica
Y Barnett1, I J Sutton2, M Ghadiri3
1From the Sydney Neuroimaging Analysis Centre (Y.B., M.H.B.), Sydney, AustraliaBrain and Mind Research Institute (Y.B., M.G., L.M., M.H.B.), University of Sydney, Sydney, AustraliaDepartment of Medical Imaging and Neurology (Y.B., I.J.S.), St Vincent's Hospital, Sydney, Australia.
Differentiating neuromyelitis optica from multiple sclerosis is crucial for treatment. Aquaporin 4 antibodies are key to neuromyelitis optica, requiring specific early, aggressive immunosuppression for better outcomes.
Area of Science:
- Neuroimmunology
- Neurology
- Radiology
Background:
- Myelitis and optic neuritis present in both multiple sclerosis (MS) and neuromyelitis optica (NMO).
- Neuromyelitis optica has a distinct pathogenesis involving aquaporin 4 (AQP4) antibodies, differentiating it from MS.
- Accurate differentiation is vital for prognosis and treatment, as MS therapies can worsen NMO.
Purpose of the Study:
- To review the current state of conventional and nonconventional MR imaging in neuromyelitis optica.
- To discuss the role of neuroimaging in diagnosing, managing, and researching NMO.
- To highlight diagnostic challenges due to evolving MR imaging patterns and limited clinical syndromes.
Main Methods:
- Review of conventional and nonconventional Magnetic Resonance (MR) imaging techniques in NMO.
- Analysis of clinical, MR imaging, and laboratory data integration for diagnosis.
- Examination of AQP4 antibody seropositivity and its associated cerebral MR imaging patterns.
Main Results:
- Current diagnostic criteria for NMO can be insensitive, particularly in limited clinical presentations.
- Expanding spectrum of cerebral MR imaging patterns in AQP4 antibody-positive individuals adds diagnostic complexity.
- MR imaging plays a critical role in the diagnosis, management, and research of NMO.
Conclusions:
- Timely and accurate differentiation of NMO from MS is imperative for appropriate treatment and improved outcomes.
- Early and aggressive immunosuppression is essential for NMO management to prevent severe disability.
- Advances in MR imaging are crucial for expanding the diagnostic capabilities and understanding of NMO spectrum disorders.
More Related Videos
08:05Bioluminescence and Near-infrared Imaging of Optic Neuritis and Brain Inflammation in the EAE Model of Multiple Sclerosis in Mice
Published on: March 1, 2017
09:29Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017